Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001213900-23-086098
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea188073-13dinvest_theratech.htm SC 13D 59837
  Complete submission text file 0001213900-23-086098.txt   61362
Mailing Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8
Business Address 2015 PEEL STREET 5TH FLOOR MONTREAL A8 H3A 1T8 514-336-7800
Theratechnologies Inc. (Subject) CIK: 0001512717 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1130
Type: SC 13D | Act: 34 | File No.: 005-86385 | Film No.: 231398561
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1001 ROBERT-BOURASSA BLVD SUITE 1000 MONTREAL A8 H3B 4L4
Business Address 1001 ROBERT-BOURASSA BLVD SUITE 1000 MONTREAL A8 H3B 4L4 15148734375
Investissement Quebec (Filed by) CIK: 0001758646 (see all company filings)

EIN.: 981010117 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: SC 13D